|
| Nishimura, Tsutomu et al. Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures. Pharmacy pract. (Granada Ed. impr.), Dec 2006, vol.4, no.4, p.168-178. ISSN 1885-642X
|
|